Exelixis Inc. (EXEL)
NASDAQ · Healthcare
Exelixis Inc. Shareholder Equity 2009–2026
Exelixis Inc. annual shareholder equity history from 2010 to 2026. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Exelixis Inc. shareholder equity as of January 2, 2026: 2.16B, a 3.69% decrease year-over-year.
- Exelixis Inc. shareholder equity for 2026 were 2.16B, a 3.69% decrease from 2025.
- Exelixis Inc. shareholder equity for 2025 were 2.24B, a 0.87% decrease from 2023.
- Exelixis Inc. shareholder equity for 2023 were 2.26B, a 9.02% decrease from 2022.
- Exelixis Inc. shareholder equity for 2022 were 2.49B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Exelixis Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2026 | $2,161 |
| 2025 | $2,244 |
| 2023 | $2,264 |
| 2022 | $2,488 |
| 2021 | $2,211 |
| 2020 | $1,686 |
| 2018 | $1,287 |
| 2017 | $285 |
| 2016 | $89 |
| 2015 | $-141 |
| 2014 | $-159 |
| 2013 | $14 |
| 2012 | $238 |
| 2011 | $91 |
| 2010 | $-228 |
Exelixis Inc. Shareholder Equity — FAQ
Exelixis Inc. (EXEL) shareholder equity over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EXEL's shareholder equity history?
The chart and table above show Exelixis Inc.'s shareholder equity by year and by quarter, including the growth rate.